Clinical Trial

Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Study acronym: L4PinPharm
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is an open-label, single center study to evaluate implementation of a pharmacist-managed delivery of L4P in a community pharmacy setting and the impact of twice-yearly vs. quarterly PrEP visits on STI rates.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-29.
Status change: Recruiting → Active, Not Recruiting 2026-03-27
Trial Details
NCT Number NCT07210125
Lead Sponsor Kelley-Ross & Associates, Inc.
Collaborators: Gilead Sciences
Conditions HIV
Enrollment 75 participants
Start Date 2025-09-16
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-02